Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Shares Issued: 2022-2025

Historic Shares Issued for Prime Medicine (PRME) over the last 2 years, with Sep 2025 value amounting to $373,000.

  • Prime Medicine's Shares Issued fell 98.07% to $373,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $38.5 million, marking a year-over-year increase of 0.47%. This contributed to the annual value of $38.1 million for FY2024, which is 5713.89% up from last year.
  • As of Q3 2025, Prime Medicine's Shares Issued stood at $373,000, which was down 98.07% from $19.3 million recorded in Q3 2024.
  • Over the past 5 years, Prime Medicine's Shares Issued peaked at $185.3 million during Q4 2022, and registered a low of $63,000 during Q3 2022.
  • For the 3-year period, Prime Medicine's Shares Issued averaged around $4.9 million, with its median value being $345,500 (2023).
  • Per our database at Business Quant, Prime Medicine's Shares Issued plummeted by 99.90% in 2023 and then surged by 23,366.67% in 2024.
  • Over the past 4 years, Prime Medicine's Shares Issued (Quarterly) stood at $185.3 million in 2022, then crashed by 99.90% to $194,000 in 2023, then soared by 5,963.21% to $19.3 million in 2024, then crashed by 98.07% to $373,000 in 2025.
  • Its last three reported values are $373,000 in Q3 2025, $19.3 million for Q3 2024, and $17.6 million during Q2 2024.